Stockscreener 앱 받기
7.02
6.20%
0.41
시간 외 거래:
7.02
전일 마감가:
$6.61
열려 있는:
$6.58
하루 거래량:
3.26M
Relative Volume:
1.47
시가총액:
$2.60B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-14.62
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
+13.23%
1개월 성능:
+8.84%
6개월 성능:
+32.45%
1년 성능:
-23.70%
1일 변동 폭
$6.58
$7.175
1주일 범위
$5.875
$7.175
52주 변동 폭
$4.25
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
BHC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.02 | 2.45B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Cos (NYSE:BHC) Shares Gap UpHere's What Happened - MarketBeat
Bausch Health Companies (TSE:BHC) Stock Price Up 15.9%Here's Why - MarketBeat
5 Undervalued Stocks Under $10 Poised for Double-Digit Rebounds - Investing.com
Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Bausch Health Companies and More - GlobeNewswire
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail
Bausch Health Companies Inc. (NYSE:BHC) Q3 2025 Earnings Call Transcript - MSN
Why Bausch Health Is A Buy After Rising 10% On Third Quarter Results - Seeking Alpha
Is Bausch Health Companies Inc. stock supported by strong fundamentalsLong Setup & Free Technical Confirmation Trade Alerts - newser.com
What RSI levels show for Bausch Health Companies Inc. stockJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Should you wait for a breakout in Bausch Health Companies Inc.Entry Point & Safe Entry Momentum Stock Tips - newser.com
Is Bausch Health Companies Inc. stock a smart buy before Fed meetingDollar Strength & Growth Focused Investment Plans - newser.com
Is Bausch Health Companies Inc. stock positioned for digital transformationJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
Can Bausch Health Companies Inc. stock rebound after recent weaknessJuly 2025 Catalysts & Community Consensus Stock Picks - newser.com
How Bausch Health Companies Inc. stock reacts to fiscal policiesSell Signal & Community Consensus Trade Alerts - newser.com
Institutional scanner results for Bausch Health Companies Inc.July 2025 Opening Moves & Reliable Trade Execution Plans - newser.com
Published on: 2025-10-31 00:48:51 - newser.com
How to interpret RSI for Bausch Health Companies Inc. stock2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Bausch Health Companies Inc (BHC) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Bausch Health (BHC) Q3 2025 Earnings Transcript - AOL.com
Bausch Health Companies Inc. (BHC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Bausch: Q3 Earnings Snapshot - CTPost
BHC Stock Up on Q3 Earnings Beat, Salix and Solta Drive Sales - TradingView
Bausch Health Companies Inc. SEC 10-Q Report - TradingView
Will Bausch Health Companies Inc. stock sustain high P E ratiosJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Bausch Health Companies Inc. stock bottoming out2025 Investor Takeaways & Weekly Momentum Picks - newser.com
How supply chain issues affect Bausch Health Companies Inc. stockPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Why analysts remain bullish on Bausch Health Companies Inc. stockIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Published on: 2025-10-30 00:49:28 - newser.com
Bausch Health raises 2025 revenue guidance to $5B-$5.1B while strengthening Solta and Salix growth - MSN
Is Bausch Health Companies Inc. (BVF) stock worth buying before Fed action2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Bausch Health Q3 Adjusted Earnings and Revenue, Advance - 富途牛牛
Bausch Health Companies Turns To Profit In Q3; Stock Up In After-hours - Nasdaq
Bausch Health Companies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Bausch Health Turns A Profit And Lifts Its Outlook - Finimize
Bausch Health Raises Forecast After Beating Expectations Again - Finimize
Bausch Health rises on 2025 revenue, EBITDA guidance boost, Q3 beats - Seeking Alpha
Bausch & Lomb Corp SEC 10-Q Report - TradingView
Bausch Health Brief: Q3 GAAP Net Income Attributable of US$179 Million and GAAP Net Income of $181 Million - MarketScreener
Bausch Health Announces Third Quarter 2025 Results - ACCESS Newswire
Bausch Health leaves Medicaid, 340B program, STAT reports - TipRanks
Zacks Research Issues Pessimistic Outlook for BHC Earnings - MarketBeat
What is Zacks Research's Forecast for TSE:BHC Q3 Earnings? - MarketBeat
Is Bausch Health Companies Inc. stock inflation resilient2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Eye Health Supplements Market Is Booming Worldwide 2025-2032 | - openPR.com
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.18%
1.86%
자본화:
|
볼륨(24시간):